HCA Healthcare, Inc. $HCA Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 37,155 shares of the company’s stock after selling 2,178 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in HCA Healthcare were worth $17,346,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the business. Nordea Investment Management AB raised its stake in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after buying an additional 108,849 shares in the last quarter. Savant Capital LLC raised its stake in shares of HCA Healthcare by 37.7% in the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after buying an additional 1,246 shares in the last quarter. Hudson Bay Capital Management LP raised its stake in shares of HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after buying an additional 2,849 shares in the last quarter. Advisors Capital Management LLC raised its stake in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares in the last quarter. Finally, CWA Asset Management Group LLC raised its stake in shares of HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after buying an additional 8,733 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.2%

NYSE:HCA opened at $377.72 on Monday. The firm has a market capitalization of $83.79 billion, a price-to-earnings ratio of 12.99, a PEG ratio of 1.20 and a beta of 1.12. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The business’s fifty day moving average price is $451.94 and its 200 day moving average price is $480.89.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on HCA shares. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. UBS Group boosted their target price on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Leerink Partners cut their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. KeyCorp cut their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.